ArticleThe Journal of clinical investigation2008

CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

Ania Skowera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.